Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
J Cutan Pathol. 2021 May;48(5):637-643. doi: 10.1111/cup.13918. Epub 2020 Nov 24.
Mixed histiocytoses are a rare and recently recognized subset of histiocytic disorders that may involve the skin, characterized by the synchronous or metachronous development of lesions with Langerhans and/or non-Langerhans cell histiocytosis histopathological features. Around 10% of patients diagnosed with histiocytosis may develop a hematological malignancy, often with dramatic prognostic consequences. We hereby describe the exceptional case of a patient developing a MAP2K1-driven mixed histiocytosis with Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease, and Erdheim-Chester disease features and cutaneous involvement, progressing to a fatal and clonally-related acute myeloid leukemia. We reviewed the literature on similar cases and discussed the histopathological difficulties in their diagnosis and their clinical-pathological features.
混合组织细胞增生症是一种罕见的、最近才被认识到的组织细胞疾病亚类,可能涉及皮肤,其特征是郎格汉斯细胞和/或非郎格汉斯细胞组织细胞增生症组织病理学特征的病变同时或先后发生。大约 10%的组织细胞增生症患者可能会发展为血液系统恶性肿瘤,通常具有显著的预后后果。我们在此描述了一例罕见病例,患者患有 MAP2K1 驱动的混合组织细胞增生症,具有郎格汉斯细胞组织细胞增生症、Rosai-Dorfman-Destombes 病和 Erdheim-Chester 病的特征,并伴有皮肤受累,进展为致命的、克隆相关的急性髓系白血病。我们回顾了类似病例的文献,并讨论了其诊断的组织病理学困难及其临床病理特征。